354 related articles for article (PubMed ID: 19208854)
1. Berberine suppresses proinflammatory responses through AMPK activation in macrophages.
Jeong HW; Hsu KC; Lee JW; Ham M; Huh JY; Shin HJ; Kim WS; Kim JB
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E955-64. PubMed ID: 19208854
[TBL] [Abstract][Full Text] [Related]
2. Berberine suppresses neuroinflammatory responses through AMP-activated protein kinase activation in BV-2 microglia.
Lu DY; Tang CH; Chen YH; Wei IH
J Cell Biochem; 2010 Jun; 110(3):697-705. PubMed ID: 20512929
[TBL] [Abstract][Full Text] [Related]
3. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
[TBL] [Abstract][Full Text] [Related]
4. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
[TBL] [Abstract][Full Text] [Related]
5. Active spice-derived components can inhibit inflammatory responses of adipose tissue in obesity by suppressing inflammatory actions of macrophages and release of monocyte chemoattractant protein-1 from adipocytes.
Woo HM; Kang JH; Kawada T; Yoo H; Sung MK; Yu R
Life Sci; 2007 Feb; 80(10):926-31. PubMed ID: 17196622
[TBL] [Abstract][Full Text] [Related]
6. Biochemical pathways in the antiatherosclerotic effect of berberine.
Guo Y; Wang QZ; Li FM; Jiang X; Zuo YF; Wang L
Chin Med J (Engl); 2008 Jul; 121(13):1197-203. PubMed ID: 18710638
[TBL] [Abstract][Full Text] [Related]
7. Berberine inhibits palmitate-induced NLRP3 inflammasome activation by triggering autophagy in macrophages: A new mechanism linking berberine to insulin resistance improvement.
Zhou H; Feng L; Xu F; Sun Y; Ma Y; Zhang X; Liu H; Xu G; Wu X; Shen Y; Sun Y; Wu X; Xu Q
Biomed Pharmacother; 2017 May; 89():864-874. PubMed ID: 28282788
[TBL] [Abstract][Full Text] [Related]
8. The crosstalk between Nrf2 and AMPK signal pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice.
Mo C; Wang L; Zhang J; Numazawa S; Tang H; Tang X; Han X; Li J; Yang M; Wang Z; Wei D; Xiao H
Antioxid Redox Signal; 2014 Feb; 20(4):574-88. PubMed ID: 23875776
[TBL] [Abstract][Full Text] [Related]
9. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
[TBL] [Abstract][Full Text] [Related]
10. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue.
Moloney F; Toomey S; Noone E; Nugent A; Allan B; Loscher CE; Roche HM
Diabetes; 2007 Mar; 56(3):574-82. PubMed ID: 17327424
[TBL] [Abstract][Full Text] [Related]
11. Effects of statins on adipose tissue inflammation: their inhibitory effect on MyD88-independent IRF3/IFN-beta pathway in macrophages.
Abe M; Matsuda M; Kobayashi H; Miyata Y; Nakayama Y; Komuro R; Fukuhara A; Shimomura I
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):871-7. PubMed ID: 18323514
[TBL] [Abstract][Full Text] [Related]
12. Berberine reduces the expression of adipogenic enzymes and inflammatory molecules of 3T3-L1 adipocyte.
Choi BH; Ahn IS; Kim YH; Park JW; Lee SY; Hyun CK; Do MS
Exp Mol Med; 2006 Dec; 38(6):599-605. PubMed ID: 17202835
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol inhibition of inducible nitric oxide synthase in skeletal muscle involves AMPK but not SIRT1.
Centeno-Baez C; Dallaire P; Marette A
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E922-30. PubMed ID: 21810931
[TBL] [Abstract][Full Text] [Related]
14. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice.
Hosokawa M; Miyashita T; Nishikawa S; Emi S; Tsukui T; Beppu F; Okada T; Miyashita K
Arch Biochem Biophys; 2010 Dec; 504(1):17-25. PubMed ID: 20515643
[TBL] [Abstract][Full Text] [Related]
15. Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells.
Holy EW; Akhmedov A; Lüscher TF; Tanner FC
J Mol Cell Cardiol; 2009 Feb; 46(2):234-40. PubMed ID: 19014947
[TBL] [Abstract][Full Text] [Related]
16. Effects of a tetramethoxyhydroxyflavone p7f on the expression of inflammatory mediators in LPS-treated human synovial fibroblast and macrophage cells.
Yoon DY; Cho MC; Kim JH; Kim EJ; Kang JW; Seo EH; Shim JH; Kim SH; Lee HG; Oh GT; Hong JT; Park JW; Kim JW
J Microbiol Biotechnol; 2008 Apr; 18(4):686-94. PubMed ID: 18467862
[TBL] [Abstract][Full Text] [Related]
17. Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase.
Wang Y; Huang Y; Lam KS; Li Y; Wong WT; Ye H; Lau CW; Vanhoutte PM; Xu A
Cardiovasc Res; 2009 Jun; 82(3):484-92. PubMed ID: 19251722
[TBL] [Abstract][Full Text] [Related]
18. Involvement of proton-sensing TDAG8 in extracellular acidification-induced inhibition of proinflammatory cytokine production in peritoneal macrophages.
Mogi C; Tobo M; Tomura H; Murata N; He XD; Sato K; Kimura T; Ishizuka T; Sasaki T; Sato T; Kihara Y; Ishii S; Harada A; Okajima F
J Immunol; 2009 Mar; 182(5):3243-51. PubMed ID: 19234222
[TBL] [Abstract][Full Text] [Related]
19. Hepatoprotective effects of berberine on liver fibrosis via activation of AMP-activated protein kinase.
Li J; Pan Y; Kan M; Xiao X; Wang Y; Guan F; Zhang X; Chen L
Life Sci; 2014 Mar; 98(1):24-30. PubMed ID: 24412384
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS.
Halili MA; Andrews MR; Labzin LI; Schroder K; Matthias G; Cao C; Lovelace E; Reid RC; Le GT; Hume DA; Irvine KM; Matthias P; Fairlie DP; Sweet MJ
J Leukoc Biol; 2010 Jun; 87(6):1103-14. PubMed ID: 20200406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
